ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1413

Early Muscle Involvement in Patients with Rheumatoid Arthritis: A Large-Scale Cross-Sectional Study

Jie Pan1, Yao-Wei Zou1, Ying-Ying Zhu2, Jian-da Ma3, Jian-Zi Lin3, Tao Wu1, Ze-Hong Yang2, Xue-Pei Zhang1, Qian Zhang1, Hu-Wei Zheng1, Xiao-Ling He4, Wan-Mei Cheng4 and Lie Dai3, 1Sun Yat-Sen University, Guangzhou, China, 2Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China, 3Department of Rheumatology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China, 4Shanghai Healthare Co. Ltd, Shang hai, China

Meeting: ACR Convergence 2022

Keywords: rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2022

Title: RA – Diagnosis, Manifestations, and Outcomes Poster III

Session Type: Poster Session C

Session Time: 1:00PM-3:00PM

Background/Purpose: Muscle loss is common in long-standing rheumatoid arthritis (RA) patients. However, less is known about this unfavorable alteration of body composition (BC) and its significances in early RA.

Methods: This cross-sectional study was carried out based on our RA cohort and healthy control. Consecutive RA patients aged ≥16 years who fulfilled the 2010 American College of Rheumatology / European League Against Rheumatism classification criteria for RA were recruited. BC was assessed using bioelectric impedance analysis. Myopenia was defined as an appendicular skeletal muscle mass index (ASMI) ≤ 7.0 kg/m2 (men) and ≤ 5.7 kg/m2 (women), overfat was defined by the percentage of body fat mass (BF%) as ≥ 25% (men) and ≥ 35% for (women). Propensity score matching was performed to balance age and gender difference among early RA (disease duration ≤ 12 months), established RA patients and controls (in 1:3:3 matching).

Results: There were 2017 controls and 1008 RA patients recruited, including 190 (18.8%) early RA patients with median disease duration 7(4,11) months. Matched early RA patients (n=160) showed a higher prevalence of myopenia (41.3% vs. 15.8%, P < 0.0167), but no significant difference with matched established patients (41.3% vs. 50.4%, P > 0.0167, Table 1). Compared with established patients, early RA patients exhibited higher disease activity scores (including DAS28-CRP: median 4.76 vs. 3.93, P < 0.001) and more physical dysfunction (26.3% vs. 19.4%, P = 0.035). Higher RA disease activity scores were positively and strongly associated with myopenia in early RA patients, especially DAS28-CRP [AOR 1.680, 95% CI (1.171-2.409)]. Multivariate logistic regression analysis showed that myopenia [AOR 3.317 (95% CI 1.352-8.135)] was independently associated with physical dysfunction in early RA patients (Figure 1).

Conclusion: Our data indicates early and common muscle involvement in RA. Muscle loss is independently associated with physical dysfunction in early RA patients, which imply the importance of its early detection and further resolution is worth exploring in future.

Supporting image 1

Table 1 Comparisons of BC characteristics among early and established RA patients and healthy controls
*Propensity score matching among early and established RA patients and healthy controls in 1:3:3 matching with age and gender
Comparisons among three groups by one-way ANOVA test, or chi-squared test. P value <0.05 was defined as significant difference which was shown in bold.
#Compared early and established RA patients with healthy controls in Bonferroni correction, P < 0.0167
&Compared established RA with early RA patients in Bonferroni correction, P < 0.0167
BC, body composition; RA, rheumatoid arthritis; BMI, body mass index; ASMI, appendicular skeletal muscle mass index; BF%, percentage of body fat mass

Supporting image 2

Figure 1 Logistic regression analysis of the relevant characteristics with physical dysfunction in early and established RA patients
*Model 1 Adjusted for age, gender, smoking history, disease duration, RF status, ACPA status, and previous treatment
†Model 2 Adjusted for model 1+ DAS28-CRP (which was the most significantly associated with myopenia and overfat)
‡Model 3 Adjusted for model 2+ mTSS
§Model 4 Adjusted for model 3+BMI+ aBF%/ bASMI
OR, odds ratio in logistic regression; 95% CI, 95% confidence interval; AOR, adjusted OR
RA, rheumatoid arthritis; RF, rheumatoid factor; ACPA, anti-cyclic citrullinated peptide antibody; 28TJC, 28-joint tender joint counts; 28SJC, 28-joint swollen joint counts; PtGA, patient global assessment of disease activity; PrGA, provider global assessment of disease activity; Pain VAS, pain visual analogue scale; ESR, erythrocyte sedimentation rate; CRP, C-reactive protein; DAS28-ESR, Disease Activity Score in 28 joints with four variables including erythrocyte sedimentation rate; DAS28-CRP, Disease Activity Score in 28 joints with four variables including C-reactive protein; SDAI, Simplified Disease Activity Index; CDAI, Clinical Disease Activity Index; mTSS, modified total Sharp score; csDMARDs, conventional synthetic disease-modifying antirheumatic drugs; bDMARDs, biological disease-modifying anti-rheumatic drugs; tsDMARDs, target synthetic disease-modifying antirheumatic drugs; BMI, body mass index; ASMI, appendicular skeletal muscle mass index; BF%, percentage of body fat mass


Disclosures: J. Pan, None; Y. Zou, None; Y. Zhu, None; J. Ma, None; J. Lin, None; T. Wu, None; Z. Yang, None; X. Zhang, None; Q. Zhang, None; H. Zheng, None; X. He, None; W. Cheng, None; L. Dai, None.

To cite this abstract in AMA style:

Pan J, Zou Y, Zhu Y, Ma J, Lin J, Wu T, Yang Z, Zhang X, Zhang Q, Zheng H, He X, Cheng W, Dai L. Early Muscle Involvement in Patients with Rheumatoid Arthritis: A Large-Scale Cross-Sectional Study [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/early-muscle-involvement-in-patients-with-rheumatoid-arthritis-a-large-scale-cross-sectional-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/early-muscle-involvement-in-patients-with-rheumatoid-arthritis-a-large-scale-cross-sectional-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology